|
Volumn 74, Issue 7, 2015, Pages 1479-1480
|
Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
CERTOLIZUMAB PEGOL;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
GOLIMUMAB;
INFLIXIMAB;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RITUXIMAB;
ANTIRHEUMATIC AGENT;
ADULT;
ANKYLOSING SPONDYLITIS;
CANCER GROWTH;
CONTROLLED STUDY;
DISEASE REGISTRY;
DRUG EXPOSURE;
DRUG SAFETY;
DRUG USE;
FEMALE;
FOLLOW UP;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MEDICAL HISTORY;
PRECANCER;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
UTERINE CERVIX CANCER;
UTERINE CERVIX CARCINOMA IN SITU;
VIRUS CARRIER;
VIRUS STRAIN;
WART VIRUS;
ARTHRITIS;
CELL TRANSFORMATION;
COMORBIDITY;
COMPLICATION;
DENMARK;
DISEASE COURSE;
INCIDENCE;
MIDDLE AGED;
PAPILLOMAVIRUS INFECTIONS;
PATHOLOGY;
PRECANCEROUS CONDITIONS;
REGISTER;
RETROSPECTIVE STUDY;
RISK FACTOR;
UTERINE CERVICAL NEOPLASMS;
UTERINE CERVIX;
VIROLOGY;
ADULT;
ANTIRHEUMATIC AGENTS;
ARTHRITIS;
CELL TRANSFORMATION, NEOPLASTIC;
CERVIX UTERI;
COMORBIDITY;
DENMARK;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MIDDLE AGED;
PAPILLOMAVIRUS INFECTIONS;
PRECANCEROUS CONDITIONS;
REGISTRIES;
RETROSPECTIVE STUDIES;
RISK FACTORS;
UTERINE CERVICAL NEOPLASMS;
|
EID: 84934938822
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: 10.1136/annrheumdis-2014-206909 Document Type: Letter |
Times cited : (16)
|
References (10)
|